Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer

OBJECTIVE: The oncoprotein, hepatitis B X-interacting protein (HBXIP), has been reported to play an important role in human malignancies. However, its functions in non-small cell lung cancer (NSCLC) are poorly understood. The goal of the present study was to identify the role of HBXIP in the regulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun, Sun, Bei, Ruan, Xianhui, Hou, Xiukun, Zhi, Jingtai, Meng, Xiangrui, Zheng, Xiangqian, Gao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877173/
https://www.ncbi.nlm.nih.gov/pubmed/33628588
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877173/
https://www.ncbi.nlm.nih.gov/pubmed/33628588
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0098

Ejemplares similares